Article info
PDFCommentary
Compensating for research risk: permissible but not obligatory
- Correspondence to Professor Holly Fernandez Lynch, Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; lynchhf{at}pennmedicine.upenn.edu
Citation
Compensating for research risk: permissible but not obligatory
Publication history
- Received September 14, 2020
- Accepted September 18, 2020
- First published October 13, 2020.
Online issue publication
November 27, 2020
Article Versions
- Previous version (27 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Payment in challenge studies: ethics, attitudes and a new payment for risk model
- Fair go: pay research participants properly or not at all
- Commentary on 'Payment in challenge studies: ethics, attitudes and a new payment for risk model'
- On measuring attitudes about payment for research
- Payment in challenge studies from an economics perspective
- Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants?
- Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK
- Controlled human infection with Neisseria lactamica in late pregnancy to measure horizontal transmission and microbiome changes in mother–neonate pairs: a single-arm interventional pilot study protocol
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Good reasons to vaccinate: mandatory or payment for risk?